Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

A new lipid-based formula using myristyl myristate can improve estradiol treatment for hair loss.

LGD1069 effectively prevents breast tumors in mice without toxicity.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Finasteride blocks progesterone's effect on brain activity linked to epilepsy.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Oral ivermectin effectively cured scabies with minimal side effects, and finasteride promoted hair growth in men with hair loss.

Combining eflornithine cream with laser therapy effectively reduces unwanted facial hair in women.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole doesn't work.

Ethinylestradiol/Chlormadinone Acetate is a safe and effective birth control pill that also helps regulate menstrual cycles, reduces period pain, and treats certain skin and hair conditions.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Injectable platelet-rich fibrin therapy improved hair and scalp conditions in women with excessive hair loss.

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

The treatment combination is effective and generally safe for lung cancer.

The IPL device is safe, effective, and has high patient satisfaction for hair removal.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Patients with acne vulgaris have lower serum irisin levels.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.